Suppr超能文献

布瓦西精油的气相色谱-质谱联用分析及生物医学应用:一项新报告。

GC-MS Profiling and Biomedical Applications of Essential Oil of Boiss.: A New Report.

作者信息

Shah Muddaser, Khan Faizullah, Ullah Saeed, Mohanta Tapan Kumar, Khan Ajmal, Zainab Rimsha, Rafiq Naseem, Ara Hussan, Alam Tanveer, Rehman Najeeb Ur, Al-Harrasi Ahmed

机构信息

Natural and Medical Sciences Research Center, University of Nizwa, PC 616, Birkat Al Mauz, Nizwa P.O. Box 33, Oman.

Department of Botany, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan.

出版信息

Antioxidants (Basel). 2023 Mar 7;12(3):662. doi: 10.3390/antiox12030662.

Abstract

The present study explored essential oil (ELEO) constituents for the first time, obtained via hydro-distillation by means of Gas Chromatography-Mass Spectrometry (GC-MS) profiling. The essential oil was screened in vitro against breast cancer cells, normal cell lines, α-glucosidase, carbonic anhydrase-II (CA-II), free radical scavenging and in vivo analgesic and anti-inflammatory capabilities. The GC-MS screening revealed that the ELEO comprises sixty compounds (95.25%) with the dominant constituents being camphene (16.41%), thunbergol (15.33%), limonene (4.29%), eremophilene (3.77%), and β-eudesmol (3.51%). A promising antidiabetic capacity was noticed with an IC of 9.63 ± 0.22 μg/mL by the ELEO as equated to acarbose with an IC = 377.71 ± 1.34 μg/mL, while a 162.82 ± 1.24 μg/mL inhibition was observed against CA-II. Regarding breast cancer, the ELEO offered considerable cytotoxic capabilities against the triple-negative breast cancer (MDA-MB-231) cell lines, having an IC = 183.8 ± 1.6 μg/mL. Furthermore, the ELEO was also tested with the human breast epithelial (MCF-10A) cell line, and the findings also presumed that the ELEO did not produce any damage to the tested normal cell lines. The ELEO was effective against the Gram-positive bacteria and offered a 19.8 ± 0.02 mm zone of inhibition (ZOI) against . At the same time, the maximum resistance with 18.03 ± 0.01 mm ZOI against the fungal strain was observed among the tested fungal strains. An appreciable free radical significance was observed via the DPPH assay with an IC = 133.53 ± 0.19 µg/mL as equated to the ABTS assay having an IC = 154.93 ± 0.17 µg/mL. The ELEO also offered a substantial analgesic capacity and produced 58.33% inhibition in comparison with aspirin, a 68.47% decrease in writhes, and an anti-inflammatory capability of 65.54% inhibition, as equated to the standard diclofenac sodium having 73.64% inhibition. Hence, it was concluded that the ELEO might be a natural source for the treatment of diabetes mellitus, breast cancer, analgesic, inflammatory, and antimicrobial-related diseases. Moreover, additional phytochemical and pharmacological studies are needed to isolate responsible chemical ingredients to formulate new drugs for the examined activities.

摘要

本研究首次通过气相色谱-质谱联用(GC-MS)分析,对水蒸馏法获得的精油(ELEO)成分进行了探究。该精油针对乳腺癌细胞、正常细胞系、α-葡萄糖苷酶、碳酸酐酶-II(CA-II)进行了体外筛选,并测试了其自由基清除能力以及体内镇痛和抗炎能力。GC-MS筛选显示,该精油包含60种化合物(占95.25%),主要成分有莰烯(16.41%)、thunbergol(15.33%)、柠檬烯(4.29%)、紫穗槐烯(3.77%)和β-桉叶醇(3.51%)。ELEO的抗糖尿病能力很有前景,其IC₅₀为9.63±0.22μg/mL,而阿卡波糖的IC₅₀为377.71±1.34μg/mL;同时观察到其对CA-II的抑制率为162.82±1.24μg/mL。在乳腺癌方面,ELEO对三阴性乳腺癌(MDA-MB-231)细胞系具有相当的细胞毒性,IC₅₀为183.8±1.6μg/mL。此外,还用人乳腺上皮(MCF-10A)细胞系对ELEO进行了测试,结果也表明ELEO对所测试的正常细胞系没有造成任何损伤。ELEO对革兰氏阳性菌有效,对[具体细菌名称未给出]的抑菌圈直径为19.8±0.02mm。同时,在所测试的真菌菌株中,观察到ELEO对[具体真菌菌株名称未给出]的最大抑菌圈直径为18.03±0.01mm。通过DPPH法测定,ELEO的自由基清除能力表现显著,IC₅₀为133.53±0.19μg/mL,ABTS法测定的IC₅₀为154.93±0.17μg/mL。与阿司匹林相比,ELEO还具有显著的镇痛能力,抑制率为58.33%,扭体次数减少68.47%,抗炎能力为65.54%,而标准双氯芬酸钠的抑制率为73.!4%。因此得出结论,ELEO可能是治疗糖尿病、乳腺癌、镇痛、炎症和抗菌相关疾病的天然来源。此外,还需要进行更多的植物化学和药理学研究,以分离出起作用的化学成分,从而为所研究的活性开发新药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b029/10045896/a4a30ca1a4f9/antioxidants-12-00662-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验